Table 3.
Differences in serum uric acid levels, frequency of hyperuricemia and fractional excretion of uric acid between HNF1B positive and negative patients presented for age-specific intervals.
| Parameter | Age Group | HNF1B+ | HNF1B- | p Value |
|---|---|---|---|---|
| BMI-SDS | 0–9 | 0.31 (−0.19–0.81; n = 37) | 0.32 (−0.26–0.90; n = 21) | 0.992 |
| 10–18 | 0.41 (−0.03–0.86; n = 31) | 0.36 (−0.03–0.74; n = 32) | 0.846 | |
| eGFR (mL/min/1.73 m2) |
1–9 | 112.28 (103.80–120.76; n = 33) | 128.89 (109.05–148.72; n = 17) | 0.119 |
| 10–18 | 95.01 (80.59–109.43; n = 32) | 107.89 (94.96–120.81; n = 32) | 0.180 | |
| sUA (mg/dL) | 0–9 | 4.93 (4.59–5.26; n = 35) | 4.14 (3.73–4.54; n = 33) | 0.003 |
| 10–18 | 6.50 (5.89–7.11; n = 25) | 5.63 (5.00–6.26; n = 32) | 0.052 | |
| Hyperuricemia (%) | 0–9 | 37.5% (n = 24) | 8.6% (n = 35) | 0.017 |
| 10–18 | 50% (n = 16) | 23.3% (n = 30) | 0.066 | |
| FEUA (%) | 0–9 | 7.33 (6.01–8.65; n = 25) | 6.82 (5.92–7.72; n = 25) | 0.511 |
| 10–18 | 6.16 (4.77–7.55; n = 21) | 5.60 (4.87–6.32; n = 29) | 0.425 |
Data are presented as means (95% confidence interval) or percentages. BMI-SDS, body mass index standard deviation score; eGFR, estimated glomerular filtration rate; FEUA, fractional excretion of uric acid; and sUA, serum uric acid.